Crown Holdings
CCK
$102.88
+0.98%
Crown Holdings Inc. is a global producer of metal packaging, manufacturing beverage cans, metal food cans, closures, and aerosol cans, and also has a presence in protective transport packaging through its Signode acquisition, operating within the Consumer Cyclical sector's Packaging & Containers industry. The company is a major global player in metal packaging, distinguished by its extensive international footprint with the vast majority of sales derived from Europe, South America, and Southeast Asia. The current investor narrative centers on its defensive, non-cyclical characteristics and cash flow strength, as highlighted by recent news discussing investor rotation towards packaging stocks with inflation-resistant pricing power, coupled with the company's recent move to aggressively raise its dividend to attract yield-focused investors in a higher interest rate environment.…
CCK
Crown Holdings
$102.88
Related headlines
Investment Opinion: Should I buy CCK Today?
Rating: Hold. The core thesis is that CCK presents a compelling but risky value proposition, where attractive cash flow and valuation are currently offset by severe and unresolved margin pressures, warranting a wait-and-see approach.
The stock trades at a discounted forward P/E of 12.10x and a P/S of 0.96x, which are below typical packaging sector multiples, suggesting embedded skepticism. Analyst sentiment is cautiously positive but mixed, with a wide target EPS range indicating high uncertainty. Supporting the hold rating are the strong TTM FCF of $1.098B, the defensive low-beta profile (0.752), and the 1-year price appreciation of +25.85%. However, these are counterbalanced by the alarming Q4 gross margin of 10.3%, elevated D/E of 2.06, and recent underperformance versus the market.
The thesis would upgrade to a Buy if Q1 2026 results demonstrate a clear gross margin recovery back above 15%, confirming Q4 was an anomaly. It would downgrade to a Sell if margins remain near Q4 levels or deteriorate further, or if the stock breaks below key technical support at $98.22. Relative to its history and the sector, the stock is fairly valued to slightly undervalued, but this valuation accurately reflects the significant earnings risk currently present.
Sign up to view all
CCK 12-Month Price Forecast
The outlook for CCK is one of high uncertainty centered on margin trajectory. The base case (60% probability) is a range-bound stock, as the market awaits conclusive evidence on whether profitability can recover. The compelling cash flow and valuation are real, but they are currently hostage to operational performance. The stance is neutral because the risk of permanent margin impairment (bear case) is meaningful enough to offset the attractive upside of a recovery (bull case). This neutral view would upgrade to bullish on confirmation of margin stabilization in the next quarterly report, or downgrade to bearish on a further deterioration in profitability or a break of key technical support near $98.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crown Holdings's 12-month outlook, with a consensus price target around $133.74 and implied upside of +30.0% versus the current price.
Average Target
$133.74
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$82 - $134
Analyst target range
Analyst coverage is limited with only 6 analysts providing estimates, indicating this is a mid-cap stock with moderate institutional interest which can lead to higher volatility. The consensus sentiment appears mixed but leans cautiously positive, as recent institutional ratings include actions like 'Outperform' from RBC Capital and Mizuho, a 'Buy' from Truist Securities and UBS, but also a downgrade to 'Neutral' from JP Morgan and maintained 'Equal Weight' from Wells Fargo. The target price range implied by estimated EPS is wide, with a low of $8.93 and a high of $10.71, signaling significant uncertainty and divergence in views on the company's earnings power and multiple, likely tied to debates over the sustainability of its margins and cash flow in the face of input cost inflation and economic cyclicality.
Bulls vs Bears: CCK Investment Factors
The investment debate for CCK centers on a clash between its attractive valuation and cash flow strength against severe and recent margin deterioration. The bull case is stronger on a long-term, value-oriented basis, supported by defensive metrics, strong FCF, and discounted multiples. The bear case presents a more immediate and potent threat, grounded in the alarming Q4 margin collapse which, if not a one-time anomaly, fundamentally undermines profitability. The single most important tension is whether the Q4 gross margin compression to 10.3% is a transient cost issue or a sign of structural pressure that invalidates the cash flow narrative. The resolution of this margin question will dictate the stock's direction more than any other factor.
Bullish
- Strong Free Cash Flow Generation: The company generated $1.098 billion in trailing twelve-month free cash flow, providing a robust foundation for its recently increased dividend and debt servicing. This cash flow strength underpins the defensive investment narrative, offering inflation-resistant pricing power as highlighted in recent news.
- Attractive Relative Valuation Multiples: CCK trades at a discount to typical packaging sector multiples, with a P/S of 0.96x and EV/EBITDA of 8.50x. Its forward P/E of 12.10x is also below the trailing P/E of 16.16x, indicating the market expects earnings recovery from depressed Q4 levels.
- Aggressive Dividend Increase Strategy: The company has aggressively raised its dividend to attract yield-focused investors in a higher interest rate environment, as per recent news. This strategic move enhances shareholder returns and signals confidence in its cash flow sustainability.
- Defensive, Low-Beta Profile: With a beta of 0.752, CCK is about 25% less volatile than the broader market, offering relative stability for a cyclical industrial name. This low volatility supports its role as a defensive rotation play within the consumer cyclical sector.
Bearish
- Severe Q4 Margin Compression: Gross margin collapsed to 10.3% in Q4 2025 from 18.9% in Q3, while net income fell to $149M from $214M sequentially. This sharp deterioration raises serious questions about cost control and the sustainability of profitability amidst input cost inflation.
- High Financial Leverage: The company carries a debt-to-equity ratio of 2.06, which is elevated and increases financial risk, particularly in a higher interest rate environment. While free cash flow is strong, this leverage amplifies downside risk if earnings weaken further.
- Revenue Growth Deceleration & Volatility: Q4 revenue of $3.127B represented a sequential decline from Q3's $3.202B, despite 7.72% YoY growth. This quarterly volatility and decelerating trend, coupled with a modest current ratio of 1.03, point to potential operational headwinds.
- Weak Recent Relative Performance: The stock has underperformed the S&P 500 by -1.72% over the past month and by -9.05% over the past year, signaling a loss of momentum and potential investor rotation away from the name despite its defensive characteristics.
CCK Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 1-year price change of +25.85%, but is currently experiencing a period of consolidation and volatility after a significant rally. With a current price of $107.15, it is trading at approximately 72% of its 52-week range ($83.23 to $116.62), positioning it in the upper-mid band, which suggests the stock has given back some gains from recent highs but remains well-supported above the midpoint, indicating a balance between momentum and potential value. Recent short-term momentum shows deceleration, with a 1-month gain of +5.64% but a more modest 3-month gain of +2.79%, and the stock has underperformed the S&P 500 by -1.72% over the past month, signaling a potential pause or rotation out of the name despite the longer-term strength. Key technical support is anchored at the 52-week low of $83.23, while immediate resistance sits near the 52-week high of $116.62; a decisive breakout above $116.62 would signal a resumption of the primary uptrend, whereas a breakdown below the recent swing low near $98.22 could indicate a deeper correction. The stock's beta of 0.752 indicates it is about 25% less volatile than the broader market, which is notable for a cyclical industrial name and suggests it may offer relative stability, though its recent max drawdown of -16.56% highlights periods of significant pullback risk within its trading range.
Beta
0.75
0.75x market volatility
Max Drawdown
-16.6%
Largest decline past year
52-Week Range
$87-$117
Price range past year
Annual Return
+18.6%
Cumulative gain past year
| Period | CCK Return | S&P 500 |
|---|---|---|
| 1m | +1.3% | +8.5% |
| 3m | -1.0% | +2.8% |
| 6m | +4.1% | +4.6% |
| 1y | +18.6% | +32.3% |
| ytd | -1.2% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CCK Fundamental Analysis
Revenue growth has been positive but shows signs of deceleration and quarterly volatility; the most recent Q4 2025 revenue was $3.127 billion, representing a year-over-year growth of 7.72%, but this follows a sequential decline from Q3's $3.202 billion, and gross margin compressed sharply to 10.3% in Q4 from 18.9% in Q3, indicating potential cost pressures or mix issues. The company remains profitable with net income of $149 million in Q4, but profitability metrics have weakened considerably from the prior quarter's net income of $214 million and net margin of 6.68%, with the trailing twelve-month net margin standing at 5.94%, reflecting margin compression amidst a challenging cost environment. The balance sheet carries significant financial leverage with a debt-to-equity ratio of 2.06, which elevates risk, but this is partially offset by robust cash generation, as evidenced by free cash flow TTM of $1.098 billion and a current ratio of 1.03, indicating adequate, though not strong, short-term liquidity to meet obligations.
Quarterly Revenue
$3.1B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.10%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CCK Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 16.16x, while the forward P/E is lower at 12.10x, indicating the market expects earnings growth and potentially a normalization of margins from the depressed Q4 levels. Compared to sector averages, the stock trades at a discount on a P/S basis (0.96x) and on an EV/EBITDA basis (8.50x), which are typically low multiples for the packaging sector, suggesting the market is pricing in concerns over margin sustainability and cyclical pressures rather than giving credit for its global scale and cash flow. Historically, the current trailing P/E of 16.16x sits below its own 5-year historical range evidenced in the data, which has seen peaks above 85x and troughs in negative territory, indicating the current valuation is not stretched and may reflect a more normalized, if cautious, earnings environment post the volatile pandemic period.
PE
16.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -16x~86x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, primarily stemming from the severe margin compression witnessed in Q4 2025, where gross margin halved sequentially from 18.9% to 10.3%. This erosion directly slashed net income by 30% quarter-over-quarter to $149 million, raising red flags about cost pass-through capabilities and operational efficiency. Furthermore, the company's elevated debt-to-equity ratio of 2.06 increases interest expense sensitivity, a critical vulnerability in the current higher-rate environment highlighted by recent news. While robust TTM FCF of $1.098 billion provides a cushion, a continuation of margin pressure could quickly strain cash flows dedicated to debt service and the newly aggressive dividend policy.
Market & Competitive Risks include valuation compression if the market loses faith in the earnings recovery priced into the forward P/E of 12.10x. The stock trades at a discount on P/S (0.96x) and EV/EBITDA (8.50x), but these multiples could contract further if the Q4 margin weakness persists. Its low beta of 0.752 offers some defensive appeal, but recent underperformance versus the S&P 500 (-1.72% over 1 month) suggests it is failing to capture defensive rotation benefits fully. Competitive and macro pressures on its globally diversified revenue base (Europe, South America, Southeast Asia) could further dampen growth and pricing power.
Worst-Case Scenario involves a failure to recover Q4 margins, leading to consecutive earnings misses and a breach of debt covenants. This could trigger analyst downgrades from the current mixed-but-leaning-positive sentiment, a dividend cut from its recently raised level, and a full re-rate to a distressed valuation. The realistic downside would see the stock retesting its 52-week low of $83.23, representing a potential loss of approximately -22% from the current price of $107.15. The historical max drawdown of -16.56% indicates the stock is capable of such moves within its trading range, especially if the $98.22 recent swing low support level fails.
FAQ
The key risks are, in order of severity: 1) Operational Risk: The sustainability of the alarming Q4 gross margin compression (10.3% vs. 18.9% in Q3), which directly threatens profitability. 2) Financial Risk: High financial leverage with a debt-to-equity ratio of 2.06, increasing vulnerability to rising interest rates. 3) Execution Risk: The company's ability to pass on input cost inflation in its globally diversified markets (Europe, South America, Asia). 4) Sentiment Risk: Limited analyst coverage (6 analysts) can lead to higher volatility and exaggerated price moves on news.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $100 and $112, as margins partially recover but growth remains muted. The Bull Case (25% probability) targets $117 to $125 on a full margin recovery and valuation re-rate. The Bear Case (15% probability) warns of a drop to $83-$95 if margin weakness persists. The base case is most likely, hinging on the assumption that Q4 was an anomaly but that a full return to historical margin levels is challenging. The immediate catalyst for any forecast revision is the next quarterly earnings report.
CCK appears fairly valued to slightly undervalued relative to its sector and own history, but this discount is justified by recent performance. Its forward P/E of 12.10x and P/S of 0.96x trade at a discount to typical packaging sector multiples, and its trailing P/E of 16.16x is below its own volatile 5-year historical range. The market is paying a fair price for a company with strong cash flows but significant near-term earnings uncertainty. The valuation implies the market expects only a partial recovery from the depressed Q4 margin levels, not a return to peak profitability.
CCK is a speculative buy for value investors comfortable with significant operational risk. The stock offers a compelling combination of strong free cash flow ($1.098B TTM), a recently raised dividend, and discounted valuation multiples (Forward P/E 12.10x). However, it is not a good buy for risk-averse investors, as the severe Q4 gross margin collapse to 10.3% presents a clear and present danger to the thesis. It could be a good buy for those who believe this margin issue is temporary and are willing to wait for a recovery, offering a potential 22% downside to the 52-week low versus an upside to recent highs.
CCK is more suitable for a long-term investment horizon of 2-3 years, not short-term trading. Its low beta (0.752) and dividend focus appeal to long-term holders seeking income and moderate growth. However, the current margin uncertainty requires patience to resolve, making it a poor short-term trade. The stock's recent volatility and 16.56% max drawdown also argue against a short-term hold. A long-term horizon allows the company time to execute its operational recovery and for the investor to realize the benefits of its cash flow generation and potential valuation normalization.
